These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 14568823)

  • 1. Development of generalized myasthenia gravis in patients with ocular myasthenia gravis.
    Papapetropoulos TH; Ellul J; Tsibri E
    Arch Neurol; 2003 Oct; 60(10):1491-2. PubMed ID: 14568823
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia gravis: generalized vs ocular, and children vs adults.
    Wang HS
    Arch Neurol; 2003 Oct; 60(10):1491; author reply 1492. PubMed ID: 14568824
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
    Kusuhara T; Nakajima M; Imamura A
    Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular myasthenia: clinical course and strategies for treatment].
    Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
    Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An atypical course of myasthenia gravis.
    Labana SS; Qureshi S; Nandakumar T; Cervellione KL; Venkatraman GK; Thakore H; Gintautas J
    Proc West Pharmacol Soc; 2007; 50():140-2. PubMed ID: 18605252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis.
    Chavis PS; Stickler DE; Walker A
    Arch Neurol; 2007 Dec; 64(12):1792-4. PubMed ID: 18071048
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy.
    Gilbert ME; De Sousa EA; Savino PJ
    Arch Neurol; 2007 Dec; 64(12):1790-2. PubMed ID: 18071047
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating ocular Myasthenia Gravis with inadequate evidence.
    Roach ES
    Arch Neurol; 2007 Dec; 64(12):1794-5. PubMed ID: 18071049
    [No Abstract]   [Full Text] [Related]  

  • 9. Eosinophilia, myositis, and myasthenia gravis associated with a thymoma.
    Avni I; Sharabi Y; Sadeh M; Buchman AS
    Muscle Nerve; 2006 Aug; 34(2):242-5. PubMed ID: 16506154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical polymorphism of myasthenia gravis beginning with isolated ocular symptoms; a five years retrospective analysis].
    Boumendil J; Clermont-Vignal C; Gout O; Fechner C; Dufier JL; Morax S
    J Fr Ophtalmol; 2010 Dec; 33(10):728-38. PubMed ID: 21087811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular manifestations of myasthenia. Apropos of 60 cases of myasthenia observed at the Dakar University Hospital Center].
    Wade A; Kassir M; Ndiaye IP
    J Fr Ophtalmol; 1986; 9(10):653-6. PubMed ID: 3819321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
    Cojocaru IM; Cojocaru M; Muşuroi C
    Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis with ocular involvement in older patients.
    Weizer JS; Lee AG; Coats DK
    Can J Ophthalmol; 2001 Feb; 36(1):26-33. PubMed ID: 11227387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Gotkine M; Fellig Y; Abramsky O
    Neurology; 2006 Sep; 67(5):881-3. PubMed ID: 16966558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular myasthenia gravis and autoimmune thyroiditis].
    Nguyen HN; Matern S
    Dtsch Med Wochenschr; 2000 Feb; 125(6):167-8. PubMed ID: 10700882
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia gravis.
    March GA; Johnson LN
    J Natl Med Assoc; 1993 Sep; 85(9):681-4. PubMed ID: 8120928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
    Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease.
    Fasano A; Evoli A; Piano C; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2008; 14(2):164-5. PubMed ID: 17459760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.